Jerzy Gumulka, Director at CNS Pharmaceuticals, Inc. (CNSP), bought 2,500 shares at $1.70 ($4K) on 2023-04-19, disclosed to the SEC on 2023-04-21.
Open-market purchase of $4k CNSP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |